Telix boss rules out capital raising as shares soar
MELBOURNE: Telix Pharmaceuticals boss Christian Behrenbruch has ruled out a capital raising to accelerate the… read more
Mayne Pharma set to defer capital return to investors
MELBOURNE: Mayne Pharma will defer a $65.5m capital return to shareholders by at least two… read more
18 new senior healthcare executives sought for key roles
MELBOURNE: Eighteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
